Crossject H1 FY26 net loss widens to €8.6 million; revenue falls 40% to €4.8 million

• Crossject posted H1 2026 revenue of EUR 4.8 million, down 40% year over year.
• Net loss widened to EUR 8.6 million, from EUR 4.9 million a year earlier.
• Cash climbed to EUR 12.3 million at June 30, more than doubled from Dec. 31, following a EUR 15 million capital increase.
• Equity swung to EUR 3 million, from negative EUR 4.9 million at year-end.
• Patrick Alexandre said the focus remains on ZEPIZURE registration and preparing first shipments; BARDA funding was extended to 2030 at USD 48 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crossject SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609250130OMX_____CNEWS_EN_GNW1001274496_en) on September 25, 2026, and is solely responsible for the information contained therein.